Education
About Us
Working with TipRanks
Follow Us
Strata Skin Sciences Inc (SSKN)
NASDAQ:SSKN
SSKN Stock Chart & Stats
$1.33
$0.03(0.99%)
At close: 4:00 PM EST
$1.33
$0.03(0.99%)
Day’s Range― - ―
52-Week Range$1.24 - $3.86
Previous CloseN/A
Volume547.00
Average Volume (3M)7.72M
Market Cap
$7.83M
Enterprise Value$19.94M
Total Cash (Recent Filing)$7.08M
Total Debt (Recent Filing)$16.31M
Price to Earnings (P/E)―
Beta0.17
Next Earnings
Mar 24, 2026EPS Estimate
-0.33Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding5,888,199
10 Day Avg. Volume10,725,031
30 Day Avg. Volume7,723,336
Financial Highlights & Ratios
PEG Ratio0.68
Price to Book (P/B)22.28
Price to Sales (P/S)3.30
P/FCF Ratio-76.51
Enterprise Value/Market Cap2.55
Enterprise Value/Revenue0.64
Enterprise Value/Gross Profit1.11
Enterprise Value/Ebitda-4.59
Forecast
1Y Price Target
$4.00Price Target Upside200.75% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Leadership And StrategyDr. Dolev Rafaeli was reappointed as CEO and has implemented a strategic turnaround plan focused on direct-to-consumer marketing to drive patient volume.
Market Growth PotentialSignificant opportunities in the dermatology market, with the potential for growth in the global treatment market expected to reach $44B by 2031.
Product AdvantagesThe FDA-cleared XTRAC therapy offers several advantages in the treatment of psoriasis, backed by peer-reviewed study data.
Bears Say
International RevenueThe 2Q25 revenue miss was primarily due to international weakness related to tariffs which could continue to pressure the topline through the remainder of 2025.
Strata Skin Sciences News
SSKN FAQ
What was Strata Skin Sciences Inc’s price range in the past 12 months?
Strata Skin Sciences Inc lowest stock price was $1.24 and its highest was $3.86 in the past 12 months.
What is Strata Skin Sciences Inc’s market cap?
Strata Skin Sciences Inc’s market cap is $7.83M.
When is Strata Skin Sciences Inc’s upcoming earnings report date?
Strata Skin Sciences Inc’s upcoming earnings report date is Mar 24, 2026 which is in 96 days.
How were Strata Skin Sciences Inc’s earnings last quarter?
Strata Skin Sciences Inc released its earnings results on Nov 13, 2025. The company reported $0.004 earnings per share for the quarter, beating the consensus estimate of -$0.53 by $0.534.
Is Strata Skin Sciences Inc overvalued?
According to Wall Street analysts Strata Skin Sciences Inc’s price is currently Undervalued.
Does Strata Skin Sciences Inc pay dividends?
Strata Skin Sciences Inc does not currently pay dividends.
What is Strata Skin Sciences Inc’s EPS estimate?
Strata Skin Sciences Inc’s EPS estimate is -0.33.
How many shares outstanding does Strata Skin Sciences Inc have?
Strata Skin Sciences Inc has 5,888,199 shares outstanding.
What happened to Strata Skin Sciences Inc’s price movement after its last earnings report?
Strata Skin Sciences Inc reported an EPS of $0.004 in its last earnings report, beating expectations of -$0.53. Following the earnings report the stock price went down -10.526%.
Which hedge fund is a major shareholder of Strata Skin Sciences Inc?
Currently, no hedge funds are holding shares in SSKN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Strata Skin Sciences Inc
Strata Skin Sciences (SSKN) is a medical technology company specializing in the development and commercialization of innovative solutions for the treatment of dermatological conditions. The company operates primarily in the healthcare sector, focusing on skin-related disorders, particularly through its core products that include advanced light-based therapies and proprietary devices for the treatment of acne, psoriasis, and other skin conditions. Strata's commitment to improving patient outcomes drives its research and development efforts, positioning it as a key player in the dermatology market.
SSKN Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mixed sentiment. While there were significant advancements in the expansion of addressable markets and successful litigation outcomes, the overall financial performance was hampered by a decline in total and equipment revenue due to international trade challenges.View all SSKN earnings summariesSSKN Stock 12 Month Forecast
Average Price Target
$4.00
▲(200.75% Upside)
Technical Analysis
Ownership Overview
2.92% Insiders
0.74% Mutual Funds
16.64% Other Institutional Investors
79.43% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---